Brett Hewlett - Comvita Insider

CVNZF -- USA Stock  

USD 4.08  0.00  0.00%

Mr. Brett Donald Hewlett serves as Independent Director of the Company. He was Chief Executive Officer of the Company., effective October 5, 2015. He is a current member of the New Zealand Trade and Enterprise Better by Design Advisory Board and an Independent Director of the USbased specialty medical device and pharmaceutical company Derma Sciences Inc. Brett holds significant international business development experience, including roles in emerging and developed markets. He previously served 15 years of a 20year career internationally with worldleading food packaging company, Tetra Pak. For five years he served as regional Managing Director of Tetra Paks eastern Mediterranean markets. Prior to that Brett worked as Commercial Director for Tetra Pak in Saudi Arabia and has also held other commercial and project management positions in the UK and Europe. He has run his own strategy consulting company and was an active angel investor supporting startup companies in New Zealand. Brett has a Bachelor of Food Technology degree from Massey University and a Masters of Business Administration from IMD in Switzerland.
Age: 51  CEO Since 2017      
64 7 533 1426

Brett Hewlett Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.02 % which means that it generated profit of $2.02 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 4.65 % meaning that it generated $4.65 on every $100 dollars invested by stockholders.
The company has accumulated 66.23 M in total debt with debt to equity ratio (D/E) of 50.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 6.16 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

CEO Since

John ChiminskiCatalent
Yifang WuShanghai Fosun Pharmaceutical C
Sigurdur OlafssonHikma Pharmaceuticals PLC
Robert KoremansTeva Pharmaceutical Industries
Sigurdur OlafssonTeva Pharmaceutical Industries
David BevanVifor Pharma AG
Gianni ZampieriVifor Pharma AG
Kaare SchultzH Lundbeck AS
Michael RayaHikma Pharmaceuticals PLC
Patricia AndrewsSumitomo Dainippon Pharma Co Lt
Deborah DunsireH Lundbeck AS
Erez VigodmanTeva Pharmaceutical Industries
Kaare SchultzTeva Pharmaceutical Industries
Carlo NotaristefaniTeva Pharmaceutical Industries
Stephen SaadAspen Pharmacare Holdings Limit

Entity Summary

Comvita Limited manufactures and markets natural health products. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand. Comvita operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on OTC Market.Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in 23 Wilson Road South and employs 500 people.

Comvita Limited Leadership Team

Sarah Ottrey, Independent Director
Simon Pothecary, Chief Sales Officer
Ben Shaw, Chief Marketing Officer
Paul Reid, Director
Roy Ong, Chief Marketing Officer
Patrick Brus, Chief Corporate Services Officer
Alan Bougen, Non-Executive Deputy Chairman of the Board
Maurice Prendergast, Independent Director
Scott Coulter, Deputy CEO, COO
Lucas Bunt, Independent Director
Murray Denyer, Independent Director
Sharon Hollenstein, Chief Innovation Officer
Brett Hewlett, CEO
Julianne Keast, Acting CFO
Mark Sadd, Chief Commercial Officer
Thomas Cullwick, Independent Director
Neil Craig, Non-Executive Independent Chairman of the Board
Kate Selway, Acting Chief People and Culture Officer
Edward Quilty, Non-Executive Director
RalfChristian Schlothauer, Chief Technical Officer
MBA DipT, Chief Supply Chain Officer
Sarah Kennedy, Independent Director
Colin Baskin, Chief Supply Chain Officer
Julie Chadwick, Corporate Communications Manager

Stock Performance Indicators

Current Sentiment - CVNZF

Comvita Limited Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Comvita Limited. What is your opinion about investing in Comvita Limited? Are you bullish or bearish?
50% Bullish
50% Bearish

Comvita Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Comvita and Teva Pharmaceutical. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.